A dose-response relationship that encompasses the characteristics of exposure and the spectrum of effects in a correlative manner is the most fundamental and pervasive concept of classic toxicology (1) . Thioacetamide (TA), originally used as a fungicide, is a potent hepatotoxin which has been much studied since the first report of its toxic properties (2) (3) (4) (5) . Earlier literature (6) (7) (8) suggests that an obligate intermediate metabolite of TA that binds to proteins with the formation of acetylimidolysine derivatives (9) is responsible for TA-induced hepatotoxic effects (Fig. 1) . TA stimulates DNA synthesis and mitosis in the liver of rats at doses that produce limited necrosis (10, 11) . The rise in DNA synthesis induced by TA follows a time sequence, which is similar to that seen after partial hepatectomy (12) . Rats treated with 50 mg TA/kg body weight undergo he3pa-tocellular proliferation as suggested by Hthymidine (3H-T) incorporation, which peaks 36 hr after administration (10,13).
We previously described an autoprotection model with TA (14) . The mechanism of autoprotection is an adaptive response characterized by sustained and controlled hepatocyte proliferation, resulting in tissue repair that helps to overcome massive liver injury inflicted by the lethal dose. Tissue repair mechanisms and hepatocellular regeneration have been implicated in the ultimate outcome of toxicity after injury from a variety of chemicals including carbon tetrachloride (15) (16) (17) (18) (19) and acetaminophen (20) . The emerging concept of all these studies is that, after infliction of injury, timely stimulation of tissue repair helps to restrain the progression of toxic injury leading to animal survival despite massive injury from a normally lethal dose. Interference with the tissue repair processes (14, (20) (21) (22) leads to unrestrained progression of injury, culminating in sudden hepatic failure and death. The preceding findings suggest that, in addition to inflicting tissue injury, toxic chemicals elicit a biological compensatory mechanism of tissue repair intended to overcome injury through tissue healing. Because stimulation of tissue repair appears to be a simultaneous biological response that accompanies injury, measuring this response in addition to quantifying injury might be helpful in fine-tuning the predictive value of dose-response relationships. Therefore We measured 3H-T incorporation into hepatonuclear DNA using the procedure of Chang and Looney (23) as modified by Chauveau et al. (24) . The DNA content of the supernatant fraction was estimated by the diphenylamine reaction (25) .
The proliferating cell nuclear antigen study was conducted as described by Greenwell et al. (26) . Briefly, the liver sections mounted on slides were first blocked with casein and then reacted with monoclonal antibody to PCNA (Dako Corporation, Carpentaria, California). The antibody was then linked with biotinylated goat anti-mouse IgG antibody (Boehringer/ Mannheim, Indianapolis, Indiana), which was then labeled with streptavidin-conjugated peroxidase Jackson Immunoresearch, West Grove, Pennsylvania). Color was developed by exposing the peroxidaselabeled streptavidin to diaminobenzidine, which forms a brown reaction product. The sections were then counterstained with Gill's hematoxylin. Go cells were blue and did not take the PCNA stain, G1 cells were light brown in color, S-phase cell nuclei stained dark brown, and G2 cells had cytoplasmic staining with or without a speckled nuclear appearance. We counted 1000 cells in each liver section.
Means ± SE were calculated for all values. Statistical differences were determined by one-way analysis of variance followed by Duncan's multiple range test to determine which means were significantly different from each other or from controls. In all cases, p.0.05 was used as the statistical criterion to determine significant differences.
Results
Four groups of rats were treated with a 12-fold dose range of TA (50, 150, 300, and 600 mg/kg) and were observed for survival and lethality in each group for 14 days ( Table 1 ). All rats in the groups receiving the sublethal doses of TA (50, 150, and 300 mg/kg) survived at the end of the 14 days, whereas the group receiving the lethal dose of 600 mg/kg experienced 100% lethality, with all deaths occurring between 4 and 7 days.
We estimated ALT as a marker of liver injury over time (0, 6, 12, 24, 36, 48, 72, and 96 hr). Figure 2 shows the serum enzyme activity at various times after the administration of each dose of TA. In the three groups receiving the sixfold dose range of TA (50, 150, and 300 mg/kg), enzyme levels increased initially and then declined to normal, indicating liver injury followed by recovery from that injury. The 100% animal survival in these three groups was consistent with the serum ALT elevation followed by decline. ALT elevation suggests that the injury inflicted by these three doses of TA was similar at 12 and 24 hr. At 24 hr, however, ALT elevation was similar in rats that received the full 12-fold dose range of TA. After 48 hr, liver injury in the rats that received the highest dose of 600 mg/kg progressed remarkably in an accelerated fashion, and all these rats died by 4-7 days. Thus, all rats receiving the sublethal doses (50, 150, or 300 mg/kg) survived, while the rats that received the 600 mg/kg dose did not survive. It should be noted that, because liver injury assessed by ALT elevation at 24 hr was similar across the full 12-fold range of doses, neither the extent of liver injury measured at one time point nor at multiple time points (e.g, 0 to 36 hr) predict the ultimate outcome of toxicity. The elevation of SDH, measured in a similar fashion, exhibited the same trend (data not shown). We examined the liver sections stained by H&E for necrotic cells, extent of inflammation, neutrophil proliferation, and apoptotic bodies (Fig. 3) . At 6 hr, centrilobular cells were slightly swollen in both the groups receiving 300 and 600 mg/kg TA, fine vacuoles had started appearing, and sometimes pyknotic nuclei were visible in a few cells. More distinct evidences of necrosis were visible at 12 hr, irrespective of the dose. The necrosed cells were concentrated around the central vein. The nuclei were somewhat larger in the necrosed cells, and the cells around the portal area were unaffected. Extensive centrilobular necrosis started at 24 hr for both 300 and 600 mg/kg groups. In the centrilobular area, liver-cell columns were broken up; the individual cells were separated from each other and appeared to be crumbling, indicating degeneration. The injury also started to spread toward the mid-zonal area. Some larger adjoining periportal tracts were damaged and necrosed. Necrosis was very prominent and almost the same for both groups between 36 and 48 hr. Between 72 and 96 hr, the periporEnvironmental Health Perspectives -5 ME-; 9--9... tal cells in the group receiving 300 mg/kg started showing active mitosis, in sharp contrast to increased widespread necrosis approaching the periportal area. Very little mitotic activity was seen in the group receiving 600 mg/kg. Cell regenerative response indicated by S-phase DNA synthesis was found to peak between 36 and 48 hr in the group receiving the 300 mg/kg TA, but no such activity was noted in the group receiving 600 mg/kg during this time frame. Mitotic activity did appear in the group receiving the 600 mg/kg at 72 hr. However, it was much attenuated and delayed, leading to an unabated progression of injury resulting in death due to hepatic failure. With the 300 mg/kg TA treatment, however, presence of timely and adequate mitotic activity appeared to restrain the progression of injury, leading to recovery of animals from TA-induced hepatotoxicity. Figure 4 illustrates incorporation of 3H-T into hepatonuclear DNA over time following the administration of each dose of TA, measured as a marker of S-phase stimulation of cell cycle. Peak 3H-T incorporation after the administration of 50 mg/kg occurred at 36 hr, whereas treatment with three-fold and six-fold higher doses resulted in peak 3H-T incorporation at 48 hr. The magnitude of DNA synthesis due to the three-and six-fold higher sublethal doses was significantly higher. Nonetheless, this peak S-phase stimulation by a three-fold higher dose of 150 mg/kg was delayed 12 hr; it occurred at 48 hr after TA administration. With a six-fold higher dose of 300 mg/kg, although the peak DNA synthesis was also delayed by 12 hr and occurred at 48 hr, the increase included another additional increment in DNA synthesis. Treatment with the highest dose (600 mg/kg) however, resulted in an additional 24 hr delay and in a significantly attenuated S-phase synthesis of DNA. Therefore, in addition to being significantly delayed until 72 hr, the repair response was remarkably diminished. It was apparent that increase in TA dose leads to a dose-dependent temporal delay, and, beyond a threshold, a further increase in TA dose yields a diminished tissue repair response. It should be noted that at the maximally tolerated dose (MTD, 300 mg/kg), maximal S-phase stimulation was evident.
The results of 3H-T incorporation (Fig.  4) were further corroborated by the PCNA immunohistochemical staining procedure (Figs. 5-7) . Normally, most cells are in the resting phase (Go; observed at 36 hr after TA (50 mg/kg) administration. At 48 hr after the 50 mg/kg dose, most of the cells had progressed to the G2 and M phases. By 96 hr, the liver returned to normal quiescence as evidenced by the predominant number of Go cells. With the 300 mg/kg group, a maximum number of cells were seen in S phase at 48 hr (Figs. 5 and 7B) after the administration of TA. This finding is commensurate with the results of 3H-T incorporation studies (Fig. 4) 
Discussion
The ability of liver tissue to respond to tissue injury by stimulated hepatocellular regeneration has been demonstrated for TA (13) , carbon tetrachloride (16, 17, 27) , acetaminophen (20) , and a number of additional structurally and mechanistically dissimilar chemicals (27) (28) (29) (30) . Tissue repair is a biological response that accompanies chemicalinduced injury (14, 19, 27, 28) . Therefore, measuring this response in a dose-dependent and a temporal manner in parallel with injury may provide new insights on the use of dose-response relationships in predictive toxicology and risk assessment. The objective of the present study was to test the hypothesis that quantifying tissue repair response along with injury in response to a toxic chemical should yield greater insight into the mechanism of toxicity on the one hand, and increase the usefulness of the standard dose-response paradigm on the other. Because these are two simultaneous dynamic events, they should be measured during a time-course rather than at one single time point. Liver injury and tissue repair were the two parallel but opposing responses measured and were used as predictors of regression or progression of liver injury, leading to either animal recovery or death, respectively.
A comparison of serum enzyme elevation as an index of liver injury provides an interesting picture (Fig. 2) . During early time points, injury due to the sublethal doses (50, 150, and 300 mg/kg) was greater than that by the lethal dose (600 mg/kg), particularly at 12 hr. Liver injury from the highest dose was not significantly different from that inflicted by the lower three doses until 48 to 72 hr. Light microscopy of the liver sections in the groups receiving 300 and 600 mg/kg revealed that injury began at about 6 hr in both the groups. Injury was maximal in the group receiving 600 mg/kg between 36 and 48 hr, as evidenced by severe centrilobular necrosis, vacuolation, and congestion, while it was maximal between 24 and 36 hr in the group receiving the 300 mg/kg (Fig. 3) . As expected, infiltration of polymorphonuclear cells was evident at this time as a mechanism for cleaning dead cells and tissue debris from the lobules. Thereafter, the rats receiving 600 mg/kg experienced remarkably accelerated progression of injury, whereas the rats receiving 50, 150, and 300 mg/kg experienced equally remarkable recovery from injury.
Tissue repair indicated by the S-phase DNA synthesis (Figs. 4-7 In between the two threshold doses, there is a dose-related incremental biological compensatory mechanism that effectively restrains tissue injury, permitting recovery from tissue injury. As stimulated cell division and tissue repair are the foundations of the biological compensatory response (28, 29) , this observation suggests the possibility of therapeutic intervention (28) in overcoming tissue injury, regardless of the mechanism or the extent of initial infliction of that injury.
Another consideration is the ongoing debate on the concept of the maximally tolerated dose (MTD) used in long-term studies such as cancer bioassays (34, 35 
